Clinical trials are underway to determine if GLP-1 medications do indeed prioritise lean muscle mass over fat lossand, if so, what can be done to mitigate muscle loss for those who need these medications
Finally, individuals with a history of heart failure, ischaemic heart disease, unstable angina, myocardial infarction, aortic aneurysm or dissection, stroke (ischaemic or haemorrhagic stroke), cerebral infarction, transient ischaemic attack, carotid intervention or surgery, coronary stenting, percutaneous coronary intervention (PCI) or coronary artery bypass before inclusion to the cohort or prior to the index event were also excluded
Well cover the legal scope of practice for MDs versus NPs, state-by-state prescribing rules, telehealth restrictions, reimbursement realities, and the clinical rationale for psychiatrists entering this space
2021 Jun 1;33(6):1073-1075
She writes from a non-clinical, educational perspective with the intention to inform and empower, not to diagnose or prescribe